Peptide therapy TikTok claims: what the science actually supports

What's this video probably claiming?

Without a transcript, we're working from context, but @justagrownwoman's content pattern and the peptide category strongly suggest this video covers one or more of the following: personal experience with BPC-157 for injury recovery, GHK-Cu for skin and hair, or growth hormone secretagogues like CJC-1295 paired with ipamorelin for fat loss and muscle gain. Creators in this space typically frame peptides as the thing their doctor never told them about, positioning them as safer or smarter alternatives to conventional treatments. The tone is usually enthusiastic personal testimony, often including before-and-after references, dosing anecdotes, and sourcing tips. Whether the claims are reckless or reasonably grounded depends entirely on which peptides she's discussing and how she contextualizes the research. We'll update this analysis once we have the transcript.

What does the science actually show?

The honest answer is: it depends on the peptide, and the evidence quality varies dramatically. BPC-157 has genuine animal data supporting tissue repair, including Sikiric et al. (2018, Current Pharmaceutical Design) showing accelerated tendon and gut healing in rodent models, but zero completed randomized controlled trials in humans. GHK-Cu has legitimate dermatology research behind it; Pickart and Margolina (2018, Symmetry) documented collagen stimulation and wound healing properties in cell and animal studies, with some small human trials on topical application. CJC-1295 with ipamorelin does increase growth hormone pulse amplitude, confirmed by Teichman et al. (2006, Journal of Clinical Endocrinology and Metabolism), which found mean GH levels increased roughly 2- to 10-fold depending on dose. What that translates to in terms of real-world body composition or recovery in healthy adults is far less clear than TikTok would have you believe.

Where does the social media noise diverge from clinical reality?

The gap is significant. Most peptide content conflates animal study results with guaranteed human outcomes, skips over the regulatory reality that BPC-157, TB-500, and most research peptides are not FDA-approved for any human indication, and glosses over the compounding quality problem entirely. Peptides ordered from unregulated research chemical suppliers have documented purity issues. A 2021 analysis published in JAMA Internal Medicine found that a meaningful proportion of compounded injectable products tested contained incorrect active ingredient concentrations. MK-677 is frequently discussed as a peptide, but it is actually a non-peptide ghrelin mimetic with a half-life and oral bioavailability profile that distinguishes it mechanistically from true peptides. It also carries real risks: Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism) found MK-677 increased fasting glucose and worsened insulin sensitivity in older adults over 24 months. That finding rarely makes it into TikTok videos.

What should you actually know?

If you are considering peptide therapy after watching videos like this one, a few realities are worth sitting with. First, injectable peptides carry infection and dosing risks that are not trivial, particularly when self-administered without clinical supervision. Second, the compounding pharmacy you use matters enormously. Reputable compounders operate under USP 797 sterile compounding standards, third-party test their products, and require a valid prescription. Third, some peptides in this category have legitimate clinical use cases when prescribed by a licensed provider who has reviewed your labs and history. That is a very different context from watching a TikTok and ordering from a research chemical website. Fourth, Semax and Selank have almost no English-language clinical trial data; their research base is almost entirely Russian-language literature with limited peer review accessibility. Skepticism proportional to evidence is not pessimism. It is basic risk management.